Not Yet RecruitingNot Applicable

VividFlo System Validation Study

Australia10 participantsStarted 2026-08-10

Plain-language summary

This is a 10-participant study to assess the VividFlo System and surgical implantation using a modified technique.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age, Capacity \& Consent:
. Be 18 years of age or older.
. Be able to understand all study instructions, and willing to comply with all study procedures and the visit schedule.
. Provide written, informed consent to participate.
. Glaucoma in the study eye, meeting all of the following requirements:
. Diagnosed by the investigator, based upon untreated intraocular pressure, disc appearance and visual field abnormalities.
. The glaucoma type is one of:

Exclusion criteria

. Acute Angle Closure Glaucoma (AACG).
. Chronic Angle Closure Glaucoma (CACG) where the eye is phakic.
. Congenital glaucoma. Juvenile Open-Angle Glaucoma or Congenital Glaucoma.
. Secondary glaucoma of any type not specified in the inclusion criteria, including inflammatory glaucoma, active neovascular glaucoma, traumatic glaucoma, Iridocorneal Endothelial (ICE) Syndrome, and silicone oil induced glaucoma.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Primary Outcome

Timeframe: 12 months

Trial details

NCT IDNCT07754201

SponsorVividWhite Pty Ltd

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-12

Contact for this trial

Andrew Batty

+61 418 213 895 contact@vividwhite.com.au

View on ClinicalTrials.gov More Glaucoma trials